Pharmaceutical company Pfizer has with immediate effect stopped making and selling cough syrup Corex in India after the government prohibited fixed dose combination of Chlopheniramine Maleate + Codeine Syrup the company said in a regulatory filing here on Monday. This is to inform you that the government of India vide notification dated March 10 2016 has prohibited the manufacture for sale and distribution of fixed dose combination of Chlopheniramine Maleate + Codeine Syrup with immediate effect the company said in a filing with the Bombay Stock Exchange (BSE). In view of this the company has discontinued the manufacture and sale
